Ren Hong Tang

Director/Board Member at SIMCERE PHARMACEUTICAL GROUP LIMITED

Net worth: 2 M $ as of 2024-03-30

44 year

Health Technology

Consumer Services

Profile

Ren Hong Tang is currently an Executive Director at Simcere Pharmaceutical Group Ltd.
and an Executive Director at Jiangsu Simcere Pharmaceutical Co., Ltd.
Previously, he held positions as the Chairman & General Manager at Jiangsu Simcere Medical Diagnostics Co., Ltd., Associate Director-China Innovation Center at AstraZeneca Investment (China) Co. Ltd., Director at 3D Medicines, Inc., and Vice General Manager at Shanghai Shengdi Pharmaceutical Co., Ltd.
He obtained a doctorate degree from Nanyang Technological University in 2007 and an undergraduate degree from Shanghai Jiao Tong University in 2002.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SIMCERE PHARMACEUTICAL GROUP LIMITED 0.14%	2023-11-08	3,650,000 ( 0.14% )	2 M $	2024-03-30

Ren Hong Tang active positions

Companies	Position	Start
SIMCERE PHARMACEUTICAL GROUP LIMITED	Director/Board Member	2019-10-31
Jiangsu Simcere Pharmaceutical Co., Ltd. Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1995, Jiangsu Simcere Pharmaceutical Co., Ltd. is a subsidiary of Jiangsu Simcere Medical Diagnostics Co., Ltd. The private company is based in Nanjing, China. The Chinese company manufactures and sells pharmaceutical products.	Director/Board Member	-

All active positions of Ren Hong Tang

Former positions of Ren Hong Tang

Companies	Position	End
Shanghai Shengdi Pharmaceutical Co., Ltd.	Corporate Officer/Principal	2019-04-30
AstraZeneca Investment (China) Co. Ltd.	Corporate Officer/Principal	2017-07-31
Jiangsu Simcere Medical Diagnostics Co., Ltd. Jiangsu Simcere Medical Diagnostics Co., Ltd. Medical SpecialtiesHealth Technology Jiangsu Simcere Medical Diagnostics Co., Ltd. specializes in premise diagnosis. The company is based in Nanjing, China. and has subsidiaries in China. The Chinese company was founded in 2017. The CEO is Ren Hong Tang.	Chief Executive Officer	-
3D MEDICINES INC.	Director/Board Member	-

See the detail of Ren Hong Tang's experience

Training of Ren Hong Tang

Nanyang Technological University	Doctorate Degree
Shanghai Jiao Tong University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ren Hong Tang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
SIMCERE PHARMACEUTICAL GROUP LIMITED	Health Technology
3D MEDICINES INC.	Health Technology

Private companies	4
Jiangsu Simcere Pharmaceutical Co., Ltd. Jiangsu Simcere Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1995, Jiangsu Simcere Pharmaceutical Co., Ltd. is a subsidiary of Jiangsu Simcere Medical Diagnostics Co., Ltd. The private company is based in Nanjing, China. The Chinese company manufactures and sells pharmaceutical products.	Health Technology
AstraZeneca Investment (China) Co. Ltd.
Shanghai Shengdi Pharmaceutical Co., Ltd.
Jiangsu Simcere Medical Diagnostics Co., Ltd. Jiangsu Simcere Medical Diagnostics Co., Ltd. Medical SpecialtiesHealth Technology Jiangsu Simcere Medical Diagnostics Co., Ltd. specializes in premise diagnosis. The company is based in Nanjing, China. and has subsidiaries in China. The Chinese company was founded in 2017. The CEO is Ren Hong Tang.	Health Technology

See company connections

Stock Market
Insiders
Ren Hong Tang